Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
NaturalAntibody logo — Accelerating antibody discovery with AI bioinformatics solut...

NaturalAntibody

Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry

Founded 2020 Poland Poland 21 employees Grant Total: $6.48M Biotechnology, Clean Energy

General Information

Company Name NaturalAntibody
Founded Year 2020
Location Poland Poland
Employees 21
Industries Biotechnology, Clean Energy
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with NaturalAntibody. To contact NaturalAntibody, visit naturalantibody.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NaturalAntibody compare?

A PDF of NaturalAntibody and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NaturalAntibody soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NaturalAntibody

NaturalAntibody is a biotechnology startup founded in 2020 and headquartered in Poland. The company's slogan, "Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry," encapsulates its core mission. NaturalAntibody specializes in developing bioinformatics solutions to streamline the engineering of antibody-based therapeutics. By gathering, integrating, and repurposing antibody data from both public and proprietary repositories, the company leverages AI to gain insights into antibody structure, function, and diversity. This, in turn, aids researchers in expediting the design of therapeutic antibodies and enhances the safety of the drug discovery process. In June 15, 2023, NaturalAntibody secured a $100.00K grant investment to further bolster its innovative solutions. Although the details of the investor(s) behind this particular investment round are not provided, this funding is poised to fuel the startup's ongoing efforts in revolutionizing antibody discovery through AI-powered bioinformatics. With its focus on biotechnology and clean energy, NaturalAntibody stands at the forefront of leveraging advanced technology to drive impactful developments within the pharmaceutical industry.

Business keywords: Bioinformatics, Antibody discovery, Therapeutic antibodies, Drug discovery, AI solutions, Data integration, Pharmaceutical industry

Services & Products

Data-driven antibody discovery and optimization
Structural modeling and prediction
Immunogenicity and liability assessment
Machine learning and predictive analytics for antibody design and development

Target Customers

Biotech and pharmaceutical companies Research institutions Drug development professionals Bioinformatics and computational biology experts

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $100.00K -
15 Jun 2023
Seed Round PLN1.48M -
08 Jan 2023
Grant $100.00K -
10 Oct 2022
Grant $1.70M -
21 Dec 2021
Pre Seed Round PLN3.10M 1
Tar Heel Capital Pathfinder
Tar Heel Capital Pathfinder
24 Aug 2021

NaturalAntibody Alternatives & Competitors

View All Alternatives
NaturalAntibody vs
PipeBio
PipeBio Denmark

PipeBio (now part of Benchling) builds cloud-based bioinformatics software for biologics discovery.

Pre-Seed
8 employees
Biotechnology, Health and Wellness
NaturalAntibody vs
MindWalk Corp. (formerly BioStrand)
MindWalk Corp. (formerly BioStrand) United States

This page is no longer actively updated. For future updates follow: MindWalk Holdings Corp.

Grant
4 employees
Biotechnology, Life Sciences
NaturalAntibody vs
Majecules LLC.
Majecules LLC. Egypt

In-silico research services to guide your experiments, saving you time, effort and costs.

Seed
1 employees
Biopharma, Biotechnology
View all alternatives

FAQ About NaturalAntibody

Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry
NaturalAntibody was founded in 2020.
NaturalAntibody is headquartered in Poland.
NaturalAntibody operates in Biotechnology and Clean Energy. Its work centres on Bioinformatics, Antibody discovery, Therapeutic antibodies and Drug discovery. Its customers include Biotech and pharmaceutical companies, Research institutions and Drug development professionals.
NaturalAntibody has approximately 21 employees.
NaturalAntibody has completed 5 funding rounds, raising a total of $6.48M. The latest funding stage is Grant.
NaturalAntibody offers: Data-driven antibody discovery and optimization, Structural modeling and prediction, Immunogenicity and liability assessment, Machine learning and predictive analytics for antibody design and development.
Top alternatives and competitors to NaturalAntibody include PipeBio, MindWalk Corp. (formerly BioStrand), Majecules LLC., GOENOMICS GmbH, Cytocast. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NaturalAntibody and PipeBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NaturalAntibody, https://bouncewatch.com/company/naturalantibody, updated 13 April 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout